Form D · Pharmaceuticals
DERMA SCIENCES, INC.
Princeton, NJ · CIK 0000892160
Offering snapshot reported Jul 5, 2011 · SEC filing
- Reported sold
- $29.1M Offering amount: $29.1M
- Investors reported
- 18 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Jun 20, 2011 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jul 5, 2011 | Initial | $29,074,972 | No comparison | 18 | SEC filing |
| Apr 7, 2008 | Paper | Not reported | No comparison | Not reported | SEC filing |
| Nov 14, 2007 | Paper | Not reported | No comparison | Not reported | SEC filing |
| Aug 11, 2006 | Paper | Not reported | No comparison | Not reported | SEC filing |
| May 2, 2006 | Paper | Not reported | No comparison | Not reported |
Offering details
- Securities
- Equity
- Exemptions
- 06
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $1.89M
- Finders' fees
- $0
- Form D file number
- 021-162290
Sales compensation recipients
Scroll to see all columns →
| Recipient | CRD | Associated broker-dealer |
|---|---|---|
| Oppenheimer & Co. Inc. | 249 | |
| Canaccord Genuity Inc. | 1020 |
Source: Form D, filed Jul 5, 2011. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Robert C. Cole | Executive |
| Srini Conjeevaram | Director |
| Frederic Eigner | Executive |
| Brett Hewlett | Director |
| Richard J. Keim | Director |
| Robert G. Moussa | Director |
| James T. O'brien | Director |
| Edward J. Quilty | Director, Executive |
| C. Richard Stafford, Esq. | Director |
| Bruce F. Wesson | Director |
| Stephen T. Wills, Cpa, Mst | Director |
| Barry J. Wolfenson | Executive |
| John E. Yetter | Executive |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:
214 Carnegie Center, Suite 300
Princeton, NJ, 08540
Princeton, NJ, 08540